Innovations in the Spotlight

Innovations in the Spotlight

Innovations in the Spotlight

Innovation

Apr 16, 2026

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

NIJMEGEN, The Netherlands – April 16,2026 – Khondrion today announced that the first patient has been dosed in the pivotal, randomized, placebo-controlled Phase 3 KHENERFIN study (NCT 06451757) evaluating the efficacy and safety of sonlicromanol, its investigational small molecule for m.3243A>G-related Primary Mitochondrial Disease.

Innovation

Apr 16, 2026

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

NIJMEGEN, The Netherlands – April 16,2026 – Khondrion today announced that the first patient has been dosed in the pivotal, randomized, placebo-controlled Phase 3 KHENERFIN study (NCT 06451757) evaluating the efficacy and safety of sonlicromanol, its investigational small molecule for m.3243A>G-related Primary Mitochondrial Disease.

Innovation

Apr 16, 2026

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

NIJMEGEN, The Netherlands – April 16,2026 – Khondrion today announced that the first patient has been dosed in the pivotal, randomized, placebo-controlled Phase 3 KHENERFIN study (NCT 06451757) evaluating the efficacy and safety of sonlicromanol, its investigational small molecule for m.3243A>G-related Primary Mitochondrial Disease.

Innovation

Utrecht scientists reveal that metastasis-related changes occur early in colon cancer

Innovation

Utrecht scientists reveal that metastasis-related changes occur early in colon cancer

Innovation

Utrecht scientists reveal that metastasis-related changes occur early in colon cancer

Innovation

An important step forward in the fight against antimicrobial resistance (AMR)

Innovation

An important step forward in the fight against antimicrobial resistance (AMR)

Innovation

An important step forward in the fight against antimicrobial resistance (AMR)

Innovation

Syntric Medical Wins Venture Challenge Medtech Winter 2026 Edition

Innovation

Syntric Medical Wins Venture Challenge Medtech Winter 2026 Edition

Innovation

Syntric Medical Wins Venture Challenge Medtech Winter 2026 Edition

Innovation

From overlooked to in demand: Femtech in focus at Women’s Health Pitch Session at I4H2026

Innovation

From overlooked to in demand: Femtech in focus at Women’s Health Pitch Session at I4H2026

Innovation

From overlooked to in demand: Femtech in focus at Women’s Health Pitch Session at I4H2026

Innovation

UMC Utrecht Researcher Tim Sakkers Wins the I4H Young Innovator Award 2026 with ReveltaDx: Transforming Heart Disease Diagnosis in Women

Innovation

UMC Utrecht Researcher Tim Sakkers Wins the I4H Young Innovator Award 2026 with ReveltaDx: Transforming Heart Disease Diagnosis in Women

Innovation

UMC Utrecht Researcher Tim Sakkers Wins the I4H Young Innovator Award 2026 with ReveltaDx: Transforming Heart Disease Diagnosis in Women

Innovation

Oncode Institute and Ligase BioPartners scale proven oncology investment model with launch of Oncology Bridge Fund II

Innovation

Oncode Institute and Ligase BioPartners scale proven oncology investment model with launch of Oncology Bridge Fund II

Innovation

Oncode Institute and Ligase BioPartners scale proven oncology investment model with launch of Oncology Bridge Fund II

Innovation

Smart wound-monitoring patch wins international Biomaterials Hackathon 2026

Innovation

Smart wound-monitoring patch wins international Biomaterials Hackathon 2026

Innovation

Smart wound-monitoring patch wins international Biomaterials Hackathon 2026

Innovation

Biotech Booster: Ontbrekende schakel in de keten van kennis naar toepassing

Innovation

Biotech Booster: Ontbrekende schakel in de keten van kennis naar toepassing

Innovation

Biotech Booster: Ontbrekende schakel in de keten van kennis naar toepassing

Innovation

Is the AI boom over, or is the best still yet to come in the Life Sciences?

Innovation

Is the AI boom over, or is the best still yet to come in the Life Sciences?

Innovation

Is the AI boom over, or is the best still yet to come in the Life Sciences?

Load More Innovation News

Featured

MORE

Startup

Where you live should not determine whether your cancer is found in time

Startup

Where you live should not determine whether your cancer is found in time

Innovation

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

Innovation

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

Industry

PamDx Secures €13 Million Series A Funding to Advance Deployment of Diagnostic Blood Tests for Cancer Patients Treated with Immunotherapy

Industry

PamDx Secures €13 Million Series A Funding to Advance Deployment of Diagnostic Blood Tests for Cancer Patients Treated with Immunotherapy

Partnerships

Oncode Accelerator Supports International Collaboration to Develop Novel Neuroblastoma Therapy

Partnerships

Oncode Accelerator Supports International Collaboration to Develop Novel Neuroblastoma Therapy

Startup

Where you live should not determine whether your cancer is found in time

Innovation

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

Industry

PamDx Secures €13 Million Series A Funding to Advance Deployment of Diagnostic Blood Tests for Cancer Patients Treated with Immunotherapy

Advertisement

Advertisement